Introduction: Evaluate the real-world efficacy of a single intra-articular injection of carboxymethyl-chitosan (CM-chitosan), a new product class for knee osteoarthritis (OA).
Methods: This post-marketing study included adult patients with knee OA, who received a single injection of 60 mg CM-chitosan (currently marketed as KioMedineone) according to the instructions for use. Follow-up was performed at weeks 1, 12, 24, and 36.
Objective: To compare the safety and efficacy of hyaluronan (HA) injections with standard extracorporeal shock wave therapy (ESWT) in the treatment of painful midportion Achilles' tendinopathy.
Design: Multinational, prospective, randomized controlled, blinded-observer trial.
Setting: Ambulatory care.